AXS Short Innovation ETF Stock (SARK.US) Real-time Quotes - Financial Data - Analyst Ratings

TechCrunch's Startup Battlefield featured top biotech startups, including CasNx, Chipiron, Exactics, Lumos Strategies OÜ, Miraqules, Nephrogen, PraxisPro, Reme-D, and Surgicure Technologies. These startups showcased innovations in gene-editing, MRI diagnostics, rapid tests, electromagnetic therapy, nanotechnology, gene therapy, AI training, affordable diagnostics, and medical devices. The competition highlights the potential impact of these technologies in healthcare.

TechCrunch·12/25/2025 00:02

Investors reevaluate big pharma cos. as GLP-1, AI drug discovery, and healthcare trends reshape industry.

VanEck reports that major pharmaceutical firms are being reassessed by investors following advancements in GLP-1, artificial intelligence in drug discovery, and shifts in healthcare consumption habits. The reassessment has been prompted by the sector experiencing significant changes that are driving interest and scrutiny.

Unusual Whales·12/24/2025 08:54

Cathie Wood: 2026 could be a "golden year," with inflation projected at 0%.

Cathie Wood, founder of ARK Invest, predicts that inflation will be 0% by 2026, which she believes could be a "golden year." After tariffs, the risk of a government shutdown, and hawkish comments from the Federal Reserve, the market may be underestimating the extent to which inflation will approach zero if oil prices and rents continue to fall.

CoinLive·12/21/2025 22:14

CoinLive·12/21/2025 22:14

This Unstoppable Cathie Wood ETF Is Obliterating the S&P 500 This Year. Is It a Buy Ahead of 2026?

Cathie Wood is one of the most vocal bulls on Wall Street when it comes to the potential of innovative technologies.

Motley Fool·09/17/2025 18:09

Motley Fool·09/17/2025 18:09

Posts

Boss's BossDec 21

Recursion Pharmaceuticals (RXRX) 的最新股权结构

$Recursion Pharmaceuticals(RXRX.US) has a distinctive equity structure characterized by **"backing from AI giants, clustering of well-known growth funds, and regular founder share reductions"**. As of...

Boss's BossDec 05

RXRX 一周展望，By Grok

$Recursion Pharmaceuticals(RXRX.US) Recursion Pharmaceuticals Inc.（RXRX）Weekly Report (2025.11.22-11.29) The extent of your achievements can largely be seen from how much pain you can endure...